Information for Healthcare Professionals | LUCENTIS® (ranibizumab injection)

Search Preview

Information for Healthcare Professionals | LUCENTIS® (ranibizumab ...

www.lucentishcp.com/

Find important information about LUCENTIS® (ranibizumab injection) specifically tailored for healthcare professionals here. INDICATIONS LUCENTIS® ( ...

Most Used Html Elements

<div> : 174
<p> : 53
<a> : 46
<i> : 39
<span> : 33
<source> : 33
<li> : 21
<dd> : 18
<dt> : 18
<script> : 14
<picture> : 11
<img> : 11
<ul> : 8
<sup> : 7
<section> : 7
<br> : 6
<b> : 5
<meta> : 5
<link> : 5
<h6> : 5
<h5> : 4
<footer> : 3
<header> : 3
<h4> : 3

Most Used Html Classes

"section" : 26
"cq-dd-paragraph" : 15
"snippet" : 15
"imsafe-distribution-..." : 15
"ignore-glossary" : 15
"safety-reference-cal..." : 15
"safety-reference-cal..." : 15
"fa" : 13
"gene-component--call..." : 12
"gene-component--navi..." : 11
"gene-component--navi..." : 11
"gene-component--imag..." : 11
"gene-component--imag..." : 11
"exclude-from-glossar..." : 11
"gene-component--imag..." : 10
"gene-component--butt..." : 8
"gene-component--butt..." : 8
"gene-component--navi..." : 6
"gene-component--imag..." : 6
"gene-component--navi..." : 6
"gene-template__conta..." : 6
"gene-component--link..." : 6
"gene-component--link..." : 6
"gene-component--navi..." : 5
"gene-template__colum..." : 5
"gene-template__colum..." : 5
"gene-component--navi..." : 5
"gene-template__autho..." : 5
"gene-component--navi..." : 5
"fa-chevron-circle-ri..." : 4
"gene-component--call..." : 4
"gene-component--butt..." : 4
"gene-component--refe..." : 4
"gene-component--call..." : 4
"gene-component--call..." : 4
"gene-component--call..." : 4
"gene-component--audi..." : 4
"gene-component--call..." : 4
"gene-component--moda..." : 4
"gene-component--butt..." : 4
"gene-component--call..." : 4
"gene-template__callo..." : 4
"gene-component--butt..." : 4
"gene-component--audi..." : 4
"callout" : 4
"gene-component--audi..." : 4
"page" : 4
"gene-component--call..." : 4
"gene-component--audi..." : 4
"gene-component--link..." : 3
"fa-chevron-down" : 3
"gene-component--head..." : 3
"parsys" : 3
"gene-template__conte..." : 3
"gene-component--head..." : 3
"iparsys" : 3
"iparys_inherited" : 3
"image" : 2
"image-v2" : 2
"gene-component--navi..." : 2
"gene-component--navi..." : 2
"gene-component--navi..." : 2
"gene-component--navi..." : 2
"gene-component--moda..." : 2
"gene-component--moda..." : 2
"gene-component--moda..." : 2
"gene-component--audi..." : 2
"gene-component--head..." : 2
"gene-component--safe..." : 2
"gene-component--safe..." : 2
"gene-component--pi-b..." : 2
"gene-component--head..." : 2
"gene-component--pi-b..." : 2
"gene-component--audi..." : 2
"gene-component--moda..." : 2
"gene-component--moda..." : 2
"gene-component--moda..." : 2
"new" : 2
"gene-component--moda..." : 2
"gene-component--moda..." : 2
"gene-component--audi..." : 2
"sr-only" : 2
"gene-component--audi..." : 2
"gene-component--audi..." : 2
"fa-times" : 2

Where is www.lucentishcp.com hosted?

Country:

United States

Registrar:

SafeNames Ltd

Latitude:

34.05

Longitude:

-118.24

IP address:

72.34.128.178

IP Binary address:

1001000001000101000000010110010

IP Octal address:

11010500262

IP Hexadecimal address:

482280b2

Context analysis of lucentishcp.com

Number of letters on this page:

4 308

Number of words on this page:

963

Number of sentences on this page:

52

Average words per sentences on this page:

19

Number of syllables on this page:

1 444

Number of Bold texts:

5

Number of Italic texts:

26

Domain name architecture

Domain name length:

15

Hyphens:

Domain doesn't contain hyphens!

Domain name with Hindi letters:

ल उ च ए ञ ट इ स (h) च प . च ओ म

Domain name with Hebrew letters:

ל (u) ק(c) (e) נ ת (i) שׂ ה ק(c) פּ . ק(c) (ο) מ

Domain name with Cyrillic letters:

л у ц e н т и с х ц п . ц о м

Domain name with Arabic letters:

ل (u) (c) (e) ن ت (i) ص ح (c) (p) . (c) (o) م

Domain name with Greek letters:

λ υ χ ε ν τ ι σ (h) χ π . χ ο μ

Domain name with Chinese letters:

艾勒伊吾西伊艾娜提艾艾丝艾尺西屁 . 西哦艾马

Domain without Consonants:

lcntshcp.cm

Domain without Vowels:

uei.o

Alphabet positions:

l¹² u²¹ c³ e⁵ n¹⁴ t²⁰ i⁹ s¹⁹ h⁸ c³ p¹⁶ . c³ o¹⁵ m¹³

Domain name pattern:
V: Vowel, C: Consonant, N: Number

C V C V C C V C C C C . C V C

<HEAD> DATA INFORMATION

Encoding:

utf-8

description:

Find important information about LUCENTIS® (ranibizumab injection) specifically tailored for healthcare professionals here. INDICATIONS LUCENTIS® (ranibizumab injection) is indicated for the treatment of patients with: Neovascular (wet) age-related macular degeneration (wAMD) Macular edema following retinal vein occlusion (RVO) Diabetic macular edema (DME) Diabetic retinopathy (DR) Myopic choroidal neovascularization (mCNV) IMPORTANT SAFETY INFORMATION CONTRAINDICATIONS LUCENTIS is contraindicated in patients with ocular or periocular infections or known hypersensitivity to ranibizumab or any of the excipients in LUCENTIS. WARNINGS AND PRECAUTIONS Intravitreal injections, including those with LUCENTIS, have been associated with endophthalmitis and retinal detachment. Proper aseptic injection technique should always be utilized when administering LUCENTIS. Patients should be monitored following the injection to permit early treatment, should an infection occur. Increases in intraocular pressure (IOP) have been noted both pre-injection and post-injection (at 60 minutes) with LUCENTIS. Monitor intraocular pressure prior to and following intravitreal injection with LUCENTIS and manage appropriately. Although there was a low rate of arterial thromboembolic events (ATEs) observed in the LUCENTIS clinical trials, there is a potential risk of ATEs following intravitreal use of VEGF inhibitors. ATEs are defined as nonfatal stroke, nonfatal myocardial infarction, or vascular death (including deaths of unknown cause). Neovascular (wet) age-related macular degeneration The ATE rate in the 3 controlled neovascular AMD studies during the first year was 1.9% (17 of 874) in the combined group of patients treated with 0.3 mg or 0.5 mg LUCENTIS compared with 1.1% (5 of 441) in patients from the control arms. In the second year of Studies AMD-1 and AMD-2, the ATE rate was 2.6% (19 of 721) in the combined group of LUCENTIS-treated patients compared with 2.9% (10 of 344) in patients from the control arms. In Study AMD-4, the ATE rates observed in the study during the first year were similar to rates observed in Studies AMD-1, AMD-2, and AMD-3. In a pooled analysis of 2-year controlled studies (AMD-1, AMD-2, and a study of LUCENTIS used adjunctively with verteporfin photodynamic therapy), the stroke rate (including both ischemic and hemorrhagic stroke) was 2.7% (13 of 484) in patients treated with 0.5 mg LUCENTIS compared to 1.1% (5 of 435) in patients in the control arms (odds ratio 2.2 [95% confidence interval (0.8-7.1)]). Macular edema following retinal vein occlusion The ATE rate in the 2 controlled RVO studies during the first 6 months was 0.8% in both the LUCENTIS and control arms of the studies (4 of 525 in the combined group of patients treated with 0.3 mg or 0.5 mg LUCENTIS and 2 of 260 in the control arms). The stroke rate was 0.2% (1 of 525) in the combined group of LUCENTIS-treated patients compared to 0.4% (1 of 260) in the control arms. Diabetic macular edema and Diabetic Retinopathy In a pooled analysis of Studies DME-1 and DME-2, the ATE rate at 2 years was 7.2% (18 of 250) with 0.5 mg LUCENTIS, 5.6% (14 of 250) with 0.3 mg LUCENTIS, and 5.2% (13 of 250) with control. The stroke rate at 2 years was 3.2% (8 of 250) with 0.5 mg LUCENTIS, 1.2% (3 of 250) with 0.3 mg LUCENTIS, and 1.6% (4 of 250) with control. At 3 years, the ATE rate was 10.4% (26 of 249) with 0.5 mg LUCENTIS and 10.8% (27 of 250) with 0.3 mg LUCENTIS; the stroke rate was 4.8% (12 of 249) with 0.5 mg LUCENTIS and 2.0% (5 of 250) with 0.3 mg LUCENTIS. Fatal events occurred more frequently in patients with DME and DR at baseline treated monthly with LUCENTIS compared with control. A pooled analysis of Studies D-1 and D-2, showed that fatalities in the first 2 years occurred in 4.4% (11 of 250) of patients treated with 0.5 mg LUCENTIS, in 2.8% (7 of 250) of patients treated with 0.3 mg LUCENTIS, and in 1.2% (3 of 250) of control patients. Over 3 years, fatalities occurred in 6.4% (16 of 249) of patients treated with 0.5 mg LUCENTIS and in 4.4% (11 of 250) of patients treated with 0.3 mg LUCENTIS. Although the rate of fatal events was low and included causes of death typical of patients with advanced diabetic complications, a potential relationship between these events and intravitreal use of VEGF inhibitors cannot be excluded. ADVERSE EVENTS Serious adverse events related to the injection procedure that occurred in <0.1% of intravitreal injections included endophthalmitis, rhegmatogenous retinal detachment, and iatrogenic traumatic cataract. In the LUCENTIS Phase III clinical trials, the most common ocular side effects included conjunctival hemorrhage, eye pain, vitreous floaters, and increased intraocular pressure. The most common non-ocular side effects included nasopharyngitis, anemia, nausea, and cough. As with all therapeutic proteins, there is the potential for an immune response in patients treated with LUCENTIS. The clinical significance of immunoreactivity to LUCENTIS is unclear at this time. For additional safety information, please see LUCENTIS full Prescribing Information.

viewport:

width=device-width, initial-scale=1

Possible email addresses for lucentishcp.com

info@lucentishcp.com
email@lucentishcp.com
support@lucentishcp.com
contact@lucentishcp.com
admin@lucentishcp.com
postmaster@lucentishcp.com
hostmaster@lucentishcp.com
domain@lucentishcp.com
abuse@lucentishcp.com

Possible Domain Typos

www.ucentishcp.com, www.lpucentishcp.com, www.pucentishcp.com, www.loucentishcp.com, www.oucentishcp.com, www.liucentishcp.com, www.iucentishcp.com, www.lkucentishcp.com, www.kucentishcp.com, www.lmucentishcp.com, www.mucentishcp.com, www.l.ucentishcp.com, www..ucentishcp.com, www.lcentishcp.com, www.luycentishcp.com, www.lycentishcp.com, www.luhcentishcp.com, www.lhcentishcp.com, www.lujcentishcp.com, www.ljcentishcp.com, www.lukcentishcp.com, www.lkcentishcp.com, www.luicentishcp.com, www.licentishcp.com, www.lu7centishcp.com, www.l7centishcp.com, www.lu8centishcp.com, www.l8centishcp.com, www.luentishcp.com, www.lucxentishcp.com, www.luxentishcp.com, www.lucsentishcp.com, www.lusentishcp.com, www.lucdentishcp.com, www.ludentishcp.com, www.lucfentishcp.com, www.lufentishcp.com, www.lucventishcp.com, www.luventishcp.com, www.luc entishcp.com, www.lu entishcp.com, www.lucntishcp.com, www.lucewntishcp.com, www.lucwntishcp.com, www.lucesntishcp.com, www.lucsntishcp.com, www.lucedntishcp.com, www.lucdntishcp.com, www.lucefntishcp.com, www.lucfntishcp.com, www.lucerntishcp.com, www.lucrntishcp.com, www.luce3ntishcp.com, www.luc3ntishcp.com, www.luce4ntishcp.com, www.luc4ntishcp.com, www.lucetishcp.com, www.lucenbtishcp.com, www.lucebtishcp.com, www.lucengtishcp.com, www.lucegtishcp.com, www.lucenhtishcp.com, www.lucehtishcp.com, www.lucenjtishcp.com, www.lucejtishcp.com, www.lucenmtishcp.com, www.lucemtishcp.com, www.lucen tishcp.com, www.luce tishcp.com, www.lucenishcp.com, www.lucentrishcp.com, www.lucenrishcp.com, www.lucentfishcp.com, www.lucenfishcp.com, www.lucentgishcp.com, www.lucengishcp.com, www.lucenthishcp.com, www.lucenhishcp.com, www.lucentyishcp.com, www.lucenyishcp.com, www.lucent5ishcp.com, www.lucen5ishcp.com, www.lucent6ishcp.com, www.lucen6ishcp.com, www.lucentshcp.com, www.lucentiushcp.com, www.lucentushcp.com, www.lucentijshcp.com, www.lucentjshcp.com, www.lucentikshcp.com, www.lucentkshcp.com, www.lucentilshcp.com, www.lucentlshcp.com, www.lucentioshcp.com, www.lucentoshcp.com, www.lucenti8shcp.com, www.lucent8shcp.com, www.lucenti9shcp.com, www.lucent9shcp.com, www.lucenti*shcp.com, www.lucent*shcp.com, www.lucentihcp.com, www.lucentisqhcp.com, www.lucentiqhcp.com, www.lucentiswhcp.com, www.lucentiwhcp.com, www.lucentisehcp.com, www.lucentiehcp.com, www.lucentiszhcp.com, www.lucentizhcp.com, www.lucentisxhcp.com, www.lucentixhcp.com, www.lucentischcp.com, www.lucentichcp.com, www.lucentiscp.com, www.lucentishbcp.com, www.lucentisbcp.com, www.lucentishgcp.com, www.lucentisgcp.com, www.lucentishtcp.com, www.lucentistcp.com, www.lucentishycp.com, www.lucentisycp.com, www.lucentishucp.com, www.lucentisucp.com, www.lucentishjcp.com, www.lucentisjcp.com, www.lucentishmcp.com, www.lucentismcp.com, www.lucentishncp.com, www.lucentisncp.com, www.lucentishp.com, www.lucentishcxp.com, www.lucentishxp.com, www.lucentishcsp.com, www.lucentishsp.com, www.lucentishcdp.com, www.lucentishdp.com, www.lucentishcfp.com, www.lucentishfp.com, www.lucentishcvp.com, www.lucentishvp.com, www.lucentishc p.com, www.lucentish p.com, www.lucentishc.com, www.lucentishcpo.com, www.lucentishco.com, www.lucentishcpl.com, www.lucentishcl.com, www.lucentishcp0.com, www.lucentishc0.com, www.lucentishcp-.com, www.lucentishc-.com, www.lucentishcp_.com, www.lucentishc_.com,

More Sites

Learn English With Patty |

I will work with you to customize the lessons to meet your needs. Lessons can focus on: Conversation & Fluency, Pronunciation, Business English, Grammar, or

Number of used Technologies: 8
Number of used Javascript files: 8
Server Software: nginx/1.12.0
Server Location: United States / Provo - 69.89.31.199
List of used Technologies: Wordpress CMS, Google Analytics, CSS (Cascading Style Sheets), Html (HyperText Markup Language), Html5, Iframe, Javascript, jQuery, Php (Hypertext Preprocessor), Pingback

Francesco Delzio | Sito Personale

Number of used Technologies: 25
Number of used Javascript files: 25
Server Software: Microsoft-IIS/8.5
Server Location: Italy / Rome - 185.81.2.69
List of used Technologies: Wordpress CMS, CSS (Cascading Style Sheets), Font Awesome, Google Font API, Html (HyperText Markup Language), Html5, Iframe, Javascript, jQuery, MediaElement, Php (Hypertext Preprocessor), Pingback, Revslider, SVG (Scalable Vector Graphics)

Marla Monjardo

Number of used Technologies: 2
Number of used Javascript files: 2
Server Software: Apache
Server Location: United States / Sun City - 205.153.116.47
List of used Technologies: Wordpress CMS, CSS (Cascading Style Sheets), Html (HyperText Markup Language), Javascript, Php (Hypertext Preprocessor), Pingback, SVG (Scalable Vector Graphics)

JB's at The Limetree Music and Arts Festival, August 2012, North Yorkshire - Live bands onstage in JB's club tent - Buy festival tickets today

Join JB's at The Limetree Festival this summer for some quality live music in the glorious North Yorkshire countryside

Number of used Technologies: 1
Number of used Javascript files: 1
Server Software: Apache/2.4.27 (Unix)
Server Location: United Kingdom / - 79.170.44.75
List of used Technologies: CSS (Cascading Style Sheets), Html (HyperText Markup Language), Php (Hypertext Preprocessor)

The Believers

Number of used Technologies: 10
Number of used Javascript files: 10
Server Software: Apache
Server Location: United Kingdom / - 91.208.99.12
List of used Technologies: Wordpress CMS, CSS (Cascading Style Sheets), Html (HyperText Markup Language), Html5, Iframe, Javascript, jQuery, jQuery Cycle, Php (Hypertext Preprocessor), Pingback

Ferienwohnung Robbenplate - Willkommen

Mit dieser Homepage möchten wir Ihnen unser Ferienhaus vorstellen. Haben Sie Gefallen daran gefunden und sagen ja, hier möchte ich meinen Urlaub verbringen, so können Sie über den „Reiter“ Buchen und Preise bequem die Verfügbarkeit prüfen und direkt eine Onlinebuchung vornehmen.

Number of used Technologies: 2
Number of used Javascript files: 2
Server Software: Apache/2.2.16 (Debian)
Server Location: Germany / Höst - 195.225.104.93
List of used Technologies: Google Analytics, CSS (Cascading Style Sheets), Html (HyperText Markup Language), Javascript, Php (Hypertext Preprocessor)

MCKINNA Yachts - McKINNA Yachts (949) 673-4879

Yacht Builder and Broker

Number of used Technologies: 6
Number of used Javascript files: 6
Server Software: Microsoft-IIS/7.5
Server Location: United States / San Francisco - 199.34.228.55
List of used Technologies: Google Analytics, Quantcast Measurement, CSS (Cascading Style Sheets), Google Font API, Html (HyperText Markup Language), Html5, Javascript

Anna Moskal – Photographer

Number of used Technologies: 13
Number of used Javascript files: 13
Server Software: Apache/2.4
Server Location: Poland / - 86.111.240.157
List of used Technologies: Wordpress CMS, Google Analytics, CSS (Cascading Style Sheets), Flexslider, Google Font API, Html (HyperText Markup Language), Html5, Javascript, jQuery, Php (Hypertext Preprocessor), Pingback, SuperFish, SVG (Scalable Vector Graphics), Facebook Box

Noni Free Leads - Noni free leads and training | Free Leads

Nonii free leads

Number of used Technologies: 4
Number of used Javascript files: 4
Server Software: nginx
Server Location: United States / Clarks Summit - 142.0.38.201
List of used Technologies: CSS (Cascading Style Sheets), Html (HyperText Markup Language), Javascript

Taptoexpress » When you are full of thoughts!

Number of used Technologies: 8
Number of used Javascript files: 8
Server Software: Apache/2.2.29 (Unix) mod_ssl/2.2.29 OpenSSL/1.0.1e-fips mod_bwlimited/1.4
Server Location: India / - 182.18.143.140
List of used Technologies: Wordpress CMS, Google Analytics, CSS (Cascading Style Sheets), Google Font API, Html (HyperText Markup Language), Html5, Javascript, jQuery, Php (Hypertext Preprocessor), Pingback, SVG (Scalable Vector Graphics), Swf Object, CloudFront, Facebook Box

Lucentishcp.com